ArticleChemical science2025
A tetraazanaphthalene radical-bridged dysprosium single-molecule magnet with a large coercive field.
Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A High Energy Barrier DyChemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Magnetic Blocking in Fluoflavine Radical-Bridged Dilanthanide Complexes.Journal of the American Chemical Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generating strong magnetic coupling poses a fundamental challenge in the design of multinuclear lanthanide complexes. The inherently contracted nature of the valence 4f orbitals precludes the lanthanides from engaging in covalent bonding with closed-shell ligands. The employment of open-shell bridging ligands instead allows efficient interaction of the diffuse radical spin orbitals with the 4f shell of the lanthanides. Herein, we introduce the azaacene ligand, 1,4,5,8-tetraazanaphthalene (tan), into rare earth chemistry: first, we synthesized [(Cp*
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.